| 4.73 Delayed Data As of Sep 13 |  -0.01 / -0.21%Today’s Change | 1.56 Today|||52-Week Range 7.25 | +152.94% Year-to-Date |
| Previous close | 4.74 |
| Today’s open | 4.83 |
| Day’s range | 4.64 - 4.86 |
| Volume | 1,767,841 |
| Average volume (3 months) | 1,909,601 |
| Market cap | $767.3M |
| Earnings growth (last year) | +7.81% |
| Earnings growth (this year) | -136.87% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -97.71% |
| P/E ratio | 4.5 |
| Price/Sales | 1,838.09 |
| Price/Book | 8.88 |
| Today’s change | Today’s % change | |
|---|---|---|
| ANIPANI Pharmaceuticals ... | +4.05 | +5.59% |
| FIXXHomology Medicines I... | +0.12 | +0.59% |
| NXTCNextCure Inc | -0.63 | -1.67% |
| WVEWAVE Life Sciences L... | -0.16 | -0.66% |
| Next reporting date | November 4, 2019 |
| EPS forecast (this quarter) | -$0.09 |
| Annual revenue (last year) | $146.0K |
| Annual profit (last year) | -$53.1M |
| Net profit margin | -36,381.51% |
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer & Director Laurence James Neil Cooper |
President David M. Mauney |
Corporate headquarters Boston, Massachusetts |
